• Mashup Score: 4

    Dr. Steve Pergam, associate professor of the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center and the Infection Prevention Director at Seattle Cancer Care Alliance, discusses new guidance from the National Comprehensive Cancer Network’s COVID-19 Vaccination Advisory Committee, regarding a third dose of the Pfizer-BioNTech or the Moderna COVID-19 vaccines for…

    Tweet Tweets with this article
    • Dr. Steve Pergam (@PergamIC) talks with guest host @JSweetenhamMD about new guidelines from @NCCN on #COVID19 #vaccinebooster shots for patients with cancer. @ASCO @HutchIDScience https://t.co/m2nsat5EQa

  • Mashup Score: 4

    Dr. Steve Pergam, associate professor of the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center and the Infection Prevention Director at Seattle Cancer Care Alliance, discusses new guidance from the National Comprehensive Cancer Network’s COVID-19 Vaccination Advisory Committee, regarding a third dose of the Pfizer-BioNTech or the Moderna COVID-19 vaccines for…

    Tweet Tweets with this article
    • 🎧 #ASCODailyNews Podcast: @PergamIC talks w guest host @JSweetenhamMD about new guidelines from @NCCN on #COVID19 #vaccinebooster shots for pts w cancer. https://t.co/7sHObHufGW #COVID19ncancer @fredhutch @SeattleCCA @UTSWCancer

  • Mashup Score: 6

    Transcript: Dr. John Sweetenham: Hello, I’m John Sweetenham, Associate Director of Clinical Affairs at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center, and the guest host of ASCO Daily News Podcast today. I’m joined by my friend and colleague, Dr. Derek Raghavan, President of the Levine Cancer Institute to discuss a new study that he and his group published in JCO Oncology…

    Tweet Tweets with this article
    • 🎧 #ASCODailyNews Podcast: Guest host @JSweetenhamMD of @utswcancer interviews Dr. Derek Raghavan re: substantial $ savings achieved for pts of @LevineCancer following creation of a Financial Toxicity Tumor Board & this scalable approach's potential 👉 https://t.co/we8cfyH8Xa https://t.co/8arsRijezj

  • Mashup Score: 0

    Dr. John Sweetenham, associate director for clinical affairs at the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern and editor-in-chief of ASCO Daily News, discusses compelling approaches in cancer care featured at the 2021 ASCO Annual Meeting, including key studies on financial toxicity, drug prices, disparities in clinical trial accrual, and the impact of the COVID-19 pandemic…

    Tweet Tweets with this article
    • ICYMI: #ASCODailyNews Podcast 🎧 @JSweetenhamMD of @utswcancer discusses key #ASCO21 abstracts on financial toxicities, disparities in cancer #clinicaltrials, and the impact of #COVID19 on cancer screening. https://t.co/WwyN8k7BTR @UTSWNews #financialtoxicity

  • Mashup Score: 1

    On today’s episode, Dr. Pamela Kunz, director of the Center for Gastrointestinal Cancers at the Yale School of Medicine, and vice chief of Diversity, Equity and Inclusion for Medical Oncology at Yale, discusses compelling sessions from the 2021 ASCO Annual Meeting that addressed gender disparities in the global oncology workforce and sexual harassment experienced by oncologists.   Transcript:…

    Tweet Tweets with this article
    • 🎧 #ASCODailyNews Podcast: @PamelaKunzMD of @YaleCancer discusses compelling sessions on #equity from #ASCO21 that address gender disparities in the global oncology workforce and a new study on sexual harassment in oncology. Listen ➡️ https://t.co/V2yzXpDr2u

  • Mashup Score: 1

    Dr. Stephen Liu, associate professor of medicine and director of Thoracic Oncology and Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, highlights key abstracts in lung cancer featured at the 2021 ASCO Annual Meeting.   Transcript:  ASCO Daily News: Welcome to the ASCO Daily News Podcast. I’m Geraldine Carroll, a reporter for the ASCO Daily News. My guest today…

    Tweet Tweets with this article
    • With #ASCO21 behind us, take a look back at some of the lung cancer data that was shared in this #ASCODailyNews podcast episode. #LCSM https://t.co/oY7MzZeydJ

  • Mashup Score: 1

    Dr. Mitul Gandhi, medical oncologist-hematologist at Virginia Cancer Specialists of the US Oncology Network, highlights therapeutic advances in multiple myeloma featured at the 2021 ASCO Annual Meeting.   Transcript:  ASCO Daily News: Welcome to the ASCO Daily News Podcast. I’m Geraldine Carroll, a reporter for the ASCO Daily News. My guest today is Dr. Mitul Gandhi, a medical oncologist…

    Tweet Tweets with this article
    • #ASCODailyNews Podcast: Dr. Mitul Gandhi of @VCSpecialists discusses therapeutic advances in #MultipleMyeloma from #ASCO21 🎧 https://t.co/A60XjdbEXm @TheUSONetwork #mmsm

  • Mashup Score: 6

    Dr. Jason Luke, director of the Cancer Immunotherapeutics Center at UPMC Hillman Cancer Center, discusses advances in immunotherapy across the spectrum of malignancies featured at the 2021 ASCO Annual Meeting.   Transcript:  ASCO Daily News: Welcome to the ASCO Daily News podcast. I’m Geraldine Carroll, a reporter for the ASCO Daily News. My guest today is Dr. Jason Luke, the director of the…

    Tweet Tweets with this article
    • #ASCODailyNews podcast: @jasonlukemd of @UPMCHillmanCC highlights key #ASCO21 abstracts in #immunotherapy across malignancies 🎧 https://t.co/of9VGJmZb2

  • Mashup Score: 3

    Dr. Karen Winkfield, a radiation oncologist and Executive Director at the Meharry-Vanderbilt Alliance, and Jeanne Regnante, Chief Health Equity and Diversity Officer at the LUNGevity Foundation, discuss a new actionable framework published in JCO Oncology Practice that addresses disparities across the cancer care continuum in medically underserved communities in the United States.   Transcript…

    Tweet Tweets with this article
    • RT @mvalliance: The @ASCO Daily News interview with @DrWinkfield is out now! 📻Listen here: https://t.co/5aRMGUExxF #ASCO21 @mvalliance @VUM…